Agilon Health Inc (NYSE:AGL) shares, rose in value, with the stock price down by -32.01% to the previous day’s close as strong demand from buyers drove the stock to $3.72.
Actively observing the price movement in the recent trading, the stock is buoying the session at $5.47, falling within a range of $3.56 and $4.79. The value of beta (5-year monthly) is 0.388. Referring to stock’s 52-week performance, its high was $7.73, and the low was $1.50. On the whole, AGL has fluctuated by -15.48% over the past month.
With the market capitalization of Agilon Health Inc currently standing at about $1.53 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-24.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AGL’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of AGL currently trading nearly -20.90% and -8.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.65, while the 7-day volatility ratio is showing 6.68% which for the 30-day chart, stands at 7.72%. Furthermore, Agilon Health Inc (AGL)’s beta value is 0.20, and its average true range (ATR) is 0.51.
A comparison of Agilon Health Inc (AGL) with its peers suggests the former has fared considerably weaker in the market. AGL showed an intraday change of -32.01% in today’s session so far, and over the past year, it shrunk by -16.99%%.
Data on historical trading for Agilon Health Inc (NYSE:AGL) indicates that the trading volumes over the past 10 days have averaged 6.86 and over the past 3 months, they’ve averaged 5.83 million. According to company’s latest data on outstanding shares, there are 412.19 million shares outstanding.
Nearly 26.87% of Agilon Health Inc’s shares belong to company insiders and institutional investors own 71.68% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.27 million shares as on 2025-03-31, resulting in a short ratio of 3.2. According to the data, the short interest in Agilon Health Inc (AGL) stood at 1749.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 16.82 million. The stock has risen by 95.73% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGL stock heading into the next quarter.
